Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis

ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors

(2015) Shinichi Yamashita et al.   NEOPLASIA

New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells

(2012) Kuo-Pao Lai et al.   AMERICAN JOURNAL OF PATHOLOGY

Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

(2012) R. Hu et al.   CANCER RESEARCH

Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer

(2012) Reetta Virtakoivu et al.   MOLECULAR BIOLOGY OF THE CELL

Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth

(2011) David J. Mulholland et al.   CANCER CELL

Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

(2011) Brett S. Carver et al.   CANCER CELL

Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells

(2011) Defeng Xu et al.   CANCER LETTERS

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response

(2011) C. J. Ryan et al.   CLINICAL CANCER RESEARCH

Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function

(2011) Ching-Yuan Wu et al.   INTERNATIONAL JOURNAL OF CANCER

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer

(2010) Karin Jennbacken et al.   ENDOCRINE-RELATED CANCER

Androgen depletion up-regulates cadherin-11 expression in prostate cancer

(2010) Yu-Chen Lee et al.   JOURNAL OF PATHOLOGY

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

DHT Selectively Reverses Smad3-Mediated/TGF-β-Induced Responses through Transcriptional Down-Regulation of Smad3 in Prostate Epithelial Cells

(2010) Kyung Song et al.   MOLECULAR ENDOCRINOLOGY

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

(2010) Y Niu et al.   ONCOGENE

Androgen Receptor Promotes Hepatitis B Virus-Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription

(2010) M. H. Wu et al.   Science Translational Medicine

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

(2009) Z. Guo et al.   CANCER RESEARCH

Cistromics of hormone-dependent cancer

(2009) Mathieu Lupien et al.   ENDOCRINE-RELATED CANCER

Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression

(2009) Jiann-Jyh Lai et al.   JOURNAL OF CLINICAL INVESTIGATION

Transcriptional regulation of theTGF-β1promoter by androgen receptor

(2008) Wei Qi et al.   BIOCHEMICAL JOURNAL

Roles of TGFβ in metastasis

(2008) David Padua et al.   CELL RESEARCH

Divergent Effects of Castration on Prostate Cancer in TRAMP Mice: Possible Implications for Therapy

(2008) Y. Tang et al.   CLINICAL CANCER RESEARCH

Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

(2008) Grace L. Lu-Yao   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA